Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori

German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus-version 4.0.

ESMO gastrointestinal oncology·2026

A facile method for high-throughput screening of drug-eluting coatings in droplet microarrays based on ultrasonic spray deposition.

Biomaterials science·2021

Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guérin therapy-a case series.

BMC surgery·2021

Rapid build-up of high-throughput screening microarrays with biochemistry gradients via light-induced thiol-ene "click" chemistry.

Journal of materials chemistry. B·2021

Environmental exposure enhances the internalization of microplastic particles into cells.

Science advances·2020

Evaluation of urinary selenium as a biomarker of human occupational exposure to elemental and inorganic selenium.

International archives of occupational and environmental health·2019

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Real-Time Single Molecule Imaging Reveals Pathway-Selective Action of Aducanumab on Amyloid-β Aggregation.

Nano letters·2026

B-Cell Follicles in the Secondary Lymphatic Tissues Act as a Critical Microanatomical Niche for Sustained Viral Replication, Virus-Host Interaction and Damage During Chronic SIV Infection of Rhesus Macaques.

Journal of medical virology·2026

Vogt-Koyanagi-Harada disease: Recent perspectives.

Indian journal of ophthalmology·2026

Tripartite motif protein 32 overexpression promotes inflammation and pyroptosis in INS-1 cells via the NF-κB/NLRP3 signaling pathway under high glucose conditions.

Endokrynologia Polska·2026

Fast response in facial vitiligo monitored by non-invasive imaging during topical ruxolitinib treatment.

Dermatology reports·2026

Contextual laboratory interpretation of anti-topoisomerase I positivity in systemic sclerosis: a de-duplicated real-world analysis.

Clinical chemistry and laboratory medicine·2026

Related Experiment Videos

Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori

Related Concept Videos

German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus-version 4.0.

A facile method for high-throughput screening of drug-eluting coatings in droplet microarrays based on ultrasonic spray deposition.

Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guérin therapy-a case series.

Rapid build-up of high-throughput screening microarrays with biochemistry gradients via light-induced thiol-ene "click" chemistry.

Environmental exposure enhances the internalization of microplastic particles into cells.

Evaluation of urinary selenium as a biomarker of human occupational exposure to elemental and inorganic selenium.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Real-Time Single Molecule Imaging Reveals Pathway-Selective Action of Aducanumab on Amyloid-β Aggregation.

B-Cell Follicles in the Secondary Lymphatic Tissues Act as a Critical Microanatomical Niche for Sustained Viral Replication, Virus-Host Interaction and Damage During Chronic SIV Infection of Rhesus Macaques.

Vogt-Koyanagi-Harada disease: Recent perspectives.

Tripartite motif protein 32 overexpression promotes inflammation and pyroptosis in INS-1 cells via the NF-κB/NLRP3 signaling pathway under high glucose conditions.

Fast response in facial vitiligo monitored by non-invasive imaging during topical ruxolitinib treatment.

Contextual laboratory interpretation of anti-topoisomerase I positivity in systemic sclerosis: a de-duplicated real-world analysis.

Related Experiment Videos

Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori

Related Concept Videos

Related Articles